Intec Pharma Posts Q4 Net Loss Of $6.6M, Down By Nearly Half Year-Over-Year

Intec Pharma Ltd. (NASDAQ: NTEC) posted fourth-quarter and full-year 2019 results Friday, showing a quarterly net loss of around $6.6 million or 19 cents per share versus a loss of $12.6 million or 38 cents per share in the same period of 2018.

For the full year, the New York-based company reported a net loss of $47.6 million and $1.41 per share versus a loss of $43.5 million and $1.40 per share in 2018.

Intec said its R&D expenses fell from $10.3 million in the fourth quarter of 2018 to $1.8 million in the fourth quarter of 2019, …

Full story available on Benzinga.com

More Intec Pharma Posts Q4 Net Loss Of $6.6M, Down By Nearly Half Year-Over-Year